| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |